Q9Y6L6 (SO1B1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 114.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Solute carrier organic anion transporter family member 1B1 Alternative name(s): Liver-specific organic anion transporter 1 Short name=LST-1 OATP-C Sodium-independent organic anion-transporting polypeptide 2 Short name=OATP-2 Solute carrier family 21 member 6 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 691 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Mediates the Na+-independent uptake of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostaglandin E2, thromboxane B2, leukotriene C3, leukotriene E4, thyroxine and triiodothyronine. Involved in the clearance of bile acids and organic anions from the liver. Ref.1 Ref.2 Ref.10 Ref.12 |
| Subcellular location | Basolateral cell membrane; Multi-pass membrane protein. Note: Detected in basolateral membranes of hepatocytes. Ref.12 |
| Tissue specificity | Highly expressed in liver, at the basolateral membranes of centrilobular hepatocytes. Not detected in heart, brain, placenta, lung, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon and leukocyte. Ref.1 Ref.2 Ref.10 |
| Involvement in disease | Hyperbilirubinemia, Rotor type (HBLRR) [MIM:237450]: An autosomal recessive form of primary conjugated hyperbilirubinemia. Affected individuals develop mild jaundice not associated with hemolysis shortly after birth or in childhood. They have delayed plasma clearance of the unconjugated anionic dye bromsulphthalein and prominent urinary excretion of coproporphyrin I. Hepatic pigmentation is normal. |
| Sequence similarities | Belongs to the organo anion transporter (TC 2.A.60) family. [View classification] Contains 1 Kazal-like domain. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Ion transport Transport |
| Cellular component | Cell membrane Membrane |
| Coding sequence diversity | Polymorphism |
| Domain | Transmembrane Transmembrane helix |
| PTM | Disulfide bond Glycoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | bile acid and bile salt transport Traceable author statement. Source: Reactome bile acid metabolic processTraceable author statement. Source: Reactome sodium-independent organic anion transportTraceable author statement. Source: Reactome |
| Cellular_component | basolateral plasma membrane Inferred from electronic annotation. Source: UniProtKB-SubCell integral to plasma membraneTraceable author statement Ref.1. Source: ProtInc |
| Molecular_function | sodium-independent organic anion transmembrane transporter activity Traceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 691 | 691 | Solute carrier organic anion transporter family member 1B1 | PRO_0000191050 | |||||||
Regions | |||||||||||
| Topological domain | 1 – 28 | 28 | Cytoplasmic Potential | ||||||||
| Transmembrane | 29 – 48 | 20 | Helical; Name=1; Potential | ||||||||
| Topological domain | 49 – 67 | 19 | Extracellular Potential | ||||||||
| Transmembrane | 68 – 88 | 21 | Helical; Name=2; Potential | ||||||||
| Topological domain | 89 – 94 | 6 | Cytoplasmic Potential | ||||||||
| Transmembrane | 95 – 119 | 25 | Helical; Name=3; Potential | ||||||||
| Topological domain | 120 – 168 | 49 | Extracellular Potential | ||||||||
| Transmembrane | 169 – 197 | 29 | Helical; Name=4; Potential | ||||||||
| Topological domain | 198 – 216 | 19 | Cytoplasmic Potential | ||||||||
| Transmembrane | 217 – 237 | 21 | Helical; Name=5; Potential | ||||||||
| Topological domain | 238 – 255 | 18 | Extracellular Potential | ||||||||
| Transmembrane | 256 – 280 | 25 | Helical; Name=6; Potential | ||||||||
| Topological domain | 281 – 331 | 51 | Cytoplasmic Potential | ||||||||
| Transmembrane | 332 – 353 | 22 | Helical; Name=7; Potential | ||||||||
| Topological domain | 354 – 373 | 20 | Extracellular Potential | ||||||||
| Transmembrane | 374 – 397 | 24 | Helical; Name=8; Potential | ||||||||
| Topological domain | 398 – 401 | 4 | Cytoplasmic Potential | ||||||||
| Transmembrane | 402 – 425 | 24 | Helical; Name=9; Potential | ||||||||
| Topological domain | 426 – 537 | 112 | Extracellular Potential | ||||||||
| Transmembrane | 538 – 560 | 23 | Helical; Name=10; Potential | ||||||||
| Topological domain | 561 – 569 | 9 | Cytoplasmic Potential | ||||||||
| Transmembrane | 570 – 595 | 26 | Helical; Name=11; Potential | ||||||||
| Topological domain | 596 – 629 | 34 | Extracellular Potential | ||||||||
| Transmembrane | 630 – 647 | 18 | Helical; Name=12; Potential | ||||||||
| Topological domain | 648 – 691 | 44 | Cytoplasmic Potential | ||||||||
| Domain | 453 – 508 | 56 | Kazal-like | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 130 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 134 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 432 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 503 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 516 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 617 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 459 ↔ 485 | By similarity | |||||||||
| Disulfide bond | 463 ↔ 474 | By similarity | |||||||||
| Disulfide bond | 465 ↔ 489 | By similarity | |||||||||
Natural variations | |||||||||||
| Natural variant | 73 | 1 | F → L. Ref.11 Corresponds to variant rs56101265 [ dbSNP | Ensembl ]. | VAR_015070 | |||||||
| Natural variant | 82 | 1 | V → A. Ref.11 Corresponds to variant rs56061388 [ dbSNP | Ensembl ]. | VAR_015071 | |||||||
| Natural variant | 130 | 1 | N → D. Ref.2 Ref.6 Ref.9 Ref.11 Ref.12 Ref.13 Corresponds to variant rs2306283 [ dbSNP | Ensembl ]. | VAR_015072 | |||||||
| Natural variant | 151 | 1 | N → S. Corresponds to variant rs2306282 [ dbSNP | Ensembl ]. | VAR_057724 | |||||||
| Natural variant | 152 | 1 | R → K. Ref.1 Ref.11 Ref.13 | VAR_015073 | |||||||
| Natural variant | 155 | 1 | P → T Decreased transport activity. Ref.9 Ref.11 Ref.12 Corresponds to variant rs11045819 [ dbSNP | Ensembl ]. | VAR_015074 | |||||||
| Natural variant | 156 | 1 | E → G Decreased transport activity. Ref.11 | VAR_015075 | |||||||
| Natural variant | 174 | 1 | V → A Decreased transport activity. Ref.11 Ref.13 Corresponds to variant rs4149056 [ dbSNP | Ensembl ]. | VAR_015076 | |||||||
| Natural variant | 193 | 1 | L → R Strongly decreases expression at the plasma membrane; abolishes transport activity. Ref.12 | VAR_015077 | |||||||
| Natural variant | 241 | 1 | D → N. Ref.1 Ref.11 Ref.13 | VAR_015078 | |||||||
| Natural variant | 245 | 1 | I → V. Corresponds to variant rs11045852 [ dbSNP | Ensembl ]. | VAR_060108 | |||||||
| Natural variant | 353 | 1 | I → T. Ref.11 Corresponds to variant rs55901008 [ dbSNP | Ensembl ]. | VAR_015079 | |||||||
| Natural variant | 432 | 1 | N → D. Ref.11 Corresponds to variant rs56387224 [ dbSNP | Ensembl ]. | VAR_015080 | |||||||
| Natural variant | 462 | 1 | D → G. Ref.11 | VAR_015081 | |||||||
| Natural variant | 488 | 1 | G → A. Ref.11 Corresponds to variant rs59502379 [ dbSNP | Ensembl ]. | VAR_015082 | |||||||
| Natural variant | 643 | 1 | L → F. Corresponds to variant rs34671512 [ dbSNP | Ensembl ]. | VAR_057725 | |||||||
| Natural variant | 655 | 1 | D → G. Ref.11 Corresponds to variant rs56199088 [ dbSNP | Ensembl ]. | VAR_015083 | |||||||
| Natural variant | 667 | 1 | E → G. Ref.11 Corresponds to variant rs55737008 [ dbSNP | Ensembl ]. | VAR_015084 | |||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1." Abe T., Kakyo M., Tokui T., Nakagomi R., Nishio T., Nakai D., Nomura H., Unno M., Suzuki M., Naitoh T., Matsuno S., Yawo H. J. Biol. Chem. 274:17159-17163(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, VARIANTS LYS-152 AND ASN-241. Tissue: Liver. |
| [2] | "A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters." Hsiang B.H., Zhu Y., Wang Z., Wu Y., Sasseville V., Yang W.-P., Kirchgessner T.G. J. Biol. Chem. 274:37161-37168(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, VARIANT ASP-130. Tissue: Liver. |
| [3] | "A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane." Koenig J., Cui Y., Nies A.T., Keppler D. Am. J. Physiol. 278:G156-G164(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Liver. |
| [4] | Nezu J. Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Liver. |
| [5] | "Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide." Koenig J., Cui Y., Nies A.T., Keppler D. J. Biol. Chem. 275:23161-23168(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [6] | SeattleSNPs variation discovery resource Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT ASP-130. |
| [7] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Mammary gland. |
| [8] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS ASP-130 AND THR-155. |
| [10] | "Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver." van de Steeg E., Stranecky V., Hartmannova H., Noskova L., Hrebicek M., Wagenaar E., van Esch A., de Waart D.R., Oude Elferink R.P., Kenworthy K.E., Sticova E., al-Edreesi M., Knisely A.S., Kmoch S., Jirsa M., Schinkel A.H. J. Clin. Invest. 122:519-528(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY, INVOLVEMENT IN HBLRR. |
| [11] | "Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans." Tirona R.G., Leake B.F., Merino G., Kim R.B. J. Biol. Chem. 276:35669-35675(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS LEU-73; ALA-82; ASP-130; LYS-152; THR-155; GLY-156; ALA-174; ASN-241; THR-353; ASP-432; GLY-462; ALA-488; GLY-655 AND GLY-667, CHARACTERIZATION. |
| [12] | "A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter." Michalski C., Cui Y., Nies A.T., Nuessler A.K., Neuhaus P., Zanger U.M., Klein K., Eichelbaum M., Keppler D., Koenig J. J. Biol. Chem. 277:43058-43063(2002) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION OF VARIANTS ASP-130; THR-155 AND ARG-193, FUNCTION, SUBCELLULAR LOCATION. |
| [13] | "Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis." Nozawa T., Nakajima M., Tamai I., Noda K., Nezu J., Sai Y., Tsuji A., Yokoi T. J. Pharmacol. Exp. Ther. 302:804-813(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASP-130; LYS-152; ALA-174 AND ASN-241. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF060500 mRNA. Translation: AAD38323.1. AF205071 mRNA. Translation: AAF20212.1. AJ132573 mRNA. Translation: CAB62577.1. AB026257 mRNA. Translation: BAA78639.1. AJ400749 AJ400762 Genomic DNA. Translation: CAB97007.1.AY945934 Genomic DNA. Translation: AAX20114.1. AK312970 mRNA. Translation: BAG35809.1. CH471094 Genomic DNA. Translation: EAW96420.1. BC114376 mRNA. Translation: AAI14377.1. |
| IPI | IPI00295376. |
| RefSeq | NP_006437.3. NM_006446.4. |
| UniGene | Hs.449738. |
3D structure databases | |
| ProteinModelPortal | Q9Y6L6. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000256958. |
Protein family/group databases | |
| TCDB | 2.A.60.1.5. organo anion transporter (OAT) family. |
PTM databases | |
| PhosphoSite | Q9Y6L6. |
Polymorphism databases | |
| DMDM | 12643959. |
Proteomic databases | |
| PaxDb | Q9Y6L6. |
| PRIDE | Q9Y6L6. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000256958; ENSP00000256958; ENSG00000134538. |
| GeneID | 10599. |
| KEGG | hsa:10599. |
| UCSC | uc001req.4. human. |
Organism-specific databases | |
| CTD | 10599. |
| GeneCards | GC12P021284. |
| HGNC | HGNC:10959. SLCO1B1. |
| HPA | HPA050892. |
| MIM | 237450. phenotype. 604843. gene. |
| neXtProt | NX_Q9Y6L6. |
| Orphanet | 240851. Atorvastatin toxicity. 240903. Pravastatin toxicity. 240909. Rosuvastatin toxicity. 3111. Rotor syndrome. 240913. Simvastatin toxicity. 240961. Susceptibility to adverse reaction due to atorvastatin treatment. 240981. Susceptibility to adverse reaction due to pravastatin treatment. 240983. Susceptibility to adverse reaction due to rosuvastatin treatment. 240985. Susceptibility to adverse reaction due to simvastatin treatment. |
| PharmGKB | PA134865839. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG322696. |
| HOGENOM | HOG000231269. |
| HOVERGEN | HBG063896. |
| InParanoid | Q9Y6L6. |
| KO | K05043. |
| OMA | SIIHIER. |
| OrthoDB | EOG4V6ZGC. |
| PhylomeDB | Q9Y6L6. |
Enzyme and pathway databases | |
| Reactome | REACT_111217. Metabolism. REACT_15518. Transmembrane transport of small molecules. |
Gene expression databases | |
| Bgee | Q9Y6L6. |
| CleanEx | HS_LST1. HS_SLCO1B1. |
| Genevestigator | Q9Y6L6. |
Family and domain databases | |
| InterPro | IPR002350. Kazal_dom. IPR020846. MFS_dom. IPR016196. MFS_dom_general_subst_transpt. IPR004156. OA_transporter. [Graphical view] |
| PANTHER | PTHR11388. PTHR11388. 1 hit. |
| Pfam | PF07648. Kazal_2. 1 hit. PF03137. OATP. 1 hit. [Graphical view] |
| SMART | SM00280. KAZAL. 1 hit. [Graphical view] |
| SUPFAM | SSF103473. MFS_gen_substrate_transporter. 1 hit. |
| TIGRFAMs | TIGR00805. oat. 1 hit. |
| PROSITE | PS51465. KAZAL_2. 1 hit. PS50850. MFS. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | Q9Y6L6. |
| ChEMBL | CHEMBL1697668. |
| ChiTaRS | SLCO1B1. human. |
| DrugBank | DB00390. Digoxin. DB01241. Gemfibrozil. DB00175. Pravastatin. |
| GenomeRNAi | 10599. |
| NextBio | 40250. |
| SOURCE | Search... |
Entry information
| Entry name | SO1B1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9Y6L6 Secondary accession number(s): B2R7G2 Q9UH89 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
